Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Free Cash Flow: 2015-2025

Historic Free Cash Flow for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to -$15.2 million.

  • Assembly Biosciences' Free Cash Flow rose 0.45% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$55.8 million, marking a year-over-year decrease of 344.24%. This contributed to the annual value of -$51.1 million for FY2024, which is 327.43% down from last year.
  • As of Q3 2025, Assembly Biosciences' Free Cash Flow stood at -$15.2 million, which was up 9.45% from -$16.8 million recorded in Q2 2025.
  • Assembly Biosciences' 5-year Free Cash Flow high stood at $73.6 million for Q4 2023, and its period low was -$36.4 million during Q1 2021.
  • Over the past 3 years, Assembly Biosciences' median Free Cash Flow value was -$15.2 million (recorded in 2024), while the average stood at -$7.6 million.
  • In the last 5 years, Assembly Biosciences' Free Cash Flow plummeted by 277.36% in 2021 and then skyrocketed by 482.13% in 2023.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Free Cash Flow stood at -$19.4 million in 2021, then rose by 0.65% to -$19.3 million in 2022, then skyrocketed by 482.13% to $73.6 million in 2023, then plummeted by 100.55% to -$407,000 in 2024, then rose by 0.45% to -$15.2 million in 2025.
  • Its last three reported values are -$15.2 million in Q3 2025, -$16.8 million for Q2 2025, and -$23.4 million during Q1 2025.